REGENXBIO Inc. (RGNX)
NASDAQ: RGNX · Real-Time Price · USD
10.20
0.00 (0.00%)
At close: Jun 12, 2025, 4:00 PM
10.25
+0.05 (0.49%)
After-hours: Jun 12, 2025, 7:40 PM EDT

REGENXBIO Market Cap

REGENXBIO has a market cap or net worth of $511.64 million as of June 12, 2025. Its market cap has decreased by -30.38% in one year.

Market Cap
511.64M
Enterprise Value
372.43M
1-Year Change
-30.38%
Ranking
Category
Stock Price
$10.20

Market Cap Chart

Created with Highcharts 11.4.8Range1 Month1M6 Months6MYear to DateYTD1 Year1Y3 Years3Y5 Years5Y10 Years10YFull HistoryMax17 Sep 201511 Jun 2025Max ▾20162017201820192020202120222023202420250500M1,000M1,500M2,000M2,500M512M

Since September 17, 2015, REGENXBIO's market cap has decreased from $749.30M to $511.64M, a decrease of -31.72%. That is a compound annual growth rate of -3.84%.

History

DateMarket Cap% Change
Jun 11, 2025511.60M33.58%
Dec 31, 2024383.00M-51.50%
Dec 29, 2023789.70M-19.57%
Dec 30, 2022981.90M-29.79%
Dec 31, 20211.40B-17.57%
Dec 31, 20201.70B12.32%
Dec 31, 20191.51B0.48%
Dec 31, 20181.50B45.18%
Dec 29, 20171.04B110.87%
Dec 30, 2016491.10M12.43%
Dec 31, 2015436.80M-41.71%
View and export this data all the way back to 2015. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 725.92B
Johnson & Johnson 373.57B
Novo Nordisk 353.21B
AbbVie 338.27B
UnitedHealth Group 281.72B
Abbott Laboratories 235.37B
Novartis AG 231.84B
AstraZeneca 229.07B
Market Cap Rankings